Navigation Links


iHealth Lab adds new products and partners to mobile personal healthcare offering

5/21/2013
MOUNTAIN VIEW, Calif. , May 21, 2013 iHealth Lab Inc., a pioneer in the design and manufacture of wireless personal healthcare products and a powerful integrated mobile app continues to broaden its reach, announcing the release of two new fitness products to its existing lineup of wireless blood pressure monitors and scales: the Wireless Pulse Oximeter and Wireless Activity an... [Comments]

Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors

5/21/2013
NORTH BRUNSWICK, N.J. , May 21, 2013 Hurel Corporation ("Hurel"), a world-leading provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms, today announced the appointment of James S. MacDonald , PhD, DABT to the Company's Board of Directors. Dr. MacDonald is the former Executive Vice President of Preclinical Development of the Schering-... [Comments]

North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs

5/21/2013
FOREST HILLS, N.Y. , May 21, 2013  The North Shore-LIJ Health System is expanding a first-of-its-kind video monitoring system used to measure hand-washing compliance at North Shore University Hospital in Manhasset, NY , by introducing cameras in operating rooms at Forest Hills (NY) Hospital. (Photo: http://photos.prnewswire.com/prnh/20130521/NY17810 ) The new p... [Comments]

Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference

5/21/2013
WESTBURY, N.Y. , May 21, 2013  Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, announced today that Dr. Jun Ma , President and CEO of Vasomedical, Inc. will present at the Second Annual Marcum LLP MicroCa... [Comments]

BioElectronics Presents FDA Reclassification Panel

5/21/2013
FREDERICK, Md. , May 21, 2013 BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free consumer electronic devices, announced that CEO, Andrew J. Whelan is presenting today to the FDA's Medical Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments for reclassifying the company's products for over the counter sales. "I... [Comments]

Lehigh Valley Expands Fleet of Superbug-Slaying Robots

5/21/2013
ALLENTOWN, Pa. , May 21, 2013  Lehigh Valley Health Network has announced the deployment of two additional TRU-D SmartUVC TM devices, adding to its existing arsenal of five 5-foot-5 germ-killing UV disinfection robots. With seven devices taking up residence within the network, LVHN is now deploying the largest fleet of TRU-Ds in the U.S. to proactively combat superbugs an... [Comments]

Global Markets and Technologies for Optical Coherence Tomography (OCT)

5/21/2013
NEW YORK , May 21, 2013 Reportlinker.com announces that a new market research report is available in its catalogue:   Global Markets and Technologies for Optical Coherence Tomography (OCT) http://www.reportlinker.com/p01187977/Global-Markets-and-Technologies-for-Optical-Coherence-Tomography-OCT.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_... [Comments]

New Data Validates CyberKnife SBRT for Prostate Cancer Treatment

5/21/2013
SUNNYVALE, Calif. , May 21, 2013   Accuray Incorporated (Nasdaq: ARAY ), announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy (SBRT). The study followed 304 patients for a median of 5 years, a... [Comments]

Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine

5/21/2013
PARIS and TARRYTOWN, N.Y. , May 21, 2013 Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine published online the positive Phase 2a study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe allergic asthma.  Dupilumab is an investigational monoclonal... [Comments]

Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients

5/21/2013
ORLANDO, Fla. , May 21, 2013  Janssen R&D Ireland (Janssen) today announced primary efficacy and safety results from the global Phase 3 PROMISE study demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 79 percent of treatment-experienced genotype 1 chroni... [Comments]

[previous] [next]
(Date:5/21/2013)... May 21, 2013 ContinuCare Home Health, ... Department of Aging and Disability Services. After completing a ... interviews, ContinuCare Home Health was found to have ... is part of the Department of Aging and Disability ... and disability services, supports and opportunities that are ...
(Date:5/21/2013)... France: One-year results from SOURCE XT one of ... to-date reported today at EuroPCR 2013 show good ... of device success for all access approaches, valve sizes ... followed up 2688 consecutively enrolled patients (mean age 81.5 ... at 93 centres in 17 countries between July 2010 ...
(Date:5/21/2013)... The In View series , a ... channels across the country, announces it has posted a ... producers of the series proudly bring audiences across the ... manufacturing industry, health-related companies, medical facilities and more. The ... in all parts of the United States, Canada and ...
(Date:5/21/2013)... May 21, 2013 Modern couples ... help of Texas Counseling’s Sexuality and Relationship Workshops, ... the development of healthier habits for their relationship. ... for both couples and individuals at Texas Counseling. ... relationships and learn skills to develop long term ...
(Date:5/21/2013)... for scientific and technological research So Paulo Research Foundation, ... an investment estimated in US$ 680 million to support ... period of up to eleven years, subject to continuation ... Funding for the 17 RIDCs will come from FAPESP ... personnel, and infrastructure). Host institutions will participate in a ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Research at the cutting edge of knowledge 2
... pro-health messages can predict if you,ll keep that resolution ... That,s according to a new study forthcoming in ... who were already taking action to quit," says Emily ... of the Communication Neuroscience Laboratory at the U-M Institute ...
... to develop computer-assisted diagnosis tools that will provide ... consistently accurate diagnoses. "The advent of digital ... revolution in imaging technology for histopathology," according to ... Biomedical Informatics at The Ohio State University Medical ...
... the counter has not reduced the number of teenage ... sexually-transmitted diseases (STIs), according to a report by experts ... and Sourafel Girma used local health authority data to ... to offer emergency birth control at pharmacies and without ...
... Having sex while you,re pregnant is generally safe, a new ... review authors. "There are very few proven contraindications and risks ... be reassured." The primer, based on a review of ... Medical Association Journal . Some potential, but uncommon, risks ...
... to build an extra natural layer of nanoparticle-like armour has ... startlingly simple way to give drug bearing polymer vesicles (microscopic ... The Warwick researchers have been able to decorate these ... strategy in the design of vehicles for drug release, for ...
... Scientists have discovered why orchids are one of the most ... to their relationships with the bees that pollinate them and ... the American Naturalist , is the culmination of a ... College London, the Royal Botanic Gardens, Kew, and other international ...
Cached Medicine News:Health News:Resolved to quit smoking? 2Health News:Computer-assisted diagnosis tools to aid pathologists 2Health News:Computer-assisted diagnosis tools to aid pathologists 3Health News:Morning after pill linked to increase in STIs, study shows 2Health News:Morning after pill linked to increase in STIs, study shows 3Health News:Plankton inspires creation of stealth armor for slow-release microscopic drug vehicles 2Health News:Wealth of orchid varieties is down to busy bees and helpful fungi, says study 2Health News:Wealth of orchid varieties is down to busy bees and helpful fungi, says study 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products:
(Date:5/21/2013)... 2013 Kepner-Tregoe (KT), the global capability ... veteran Chris Geraghty has ... more than 20 years serving the industrial sector, ... He succeeds Ray Baxter , ... of the Board and CEO. ...
(Date:5/21/2013)... , May 21, 2013  Armada Health ... of the new Armada corporate website ( www.armadahealthcare.com ... communicate Armada,s unique and first-to-market services and its ... focused on the specialty pharmacy industry. ... of the Armada business model in delivering an ...
(Date:5/21/2013)... May 21, 2013 Hurel Corporation ("Hurel"), a ... cell-based assay platforms, today announced the appointment of ... the Company,s Board of Directors. Dr. MacDonald is the ... Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical development ... Merck & Co. in 2009. Over a ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... , ROCKVILLE, Md., Oct. 23 Novavax, Inc. (Nasdaq: NVAX ... VP and CFO, will be presenting at the 8th Annual BIO ... on October 29, 2009 at the Palace Hotel in San Francisco, ... business strategy and research and development progress. A link to ...
... Nyer Medical Group, Inc., (Nasdaq: NYER ) announced today ... business under the name Eaton Apothecary, and Nyer entered into ... sale of a substantial portion of DAW,s operating assets, including ... pharmacies which includes the assignment of eight leases, for a ...
Cached Medicine Technology:Novavax to Present at 8th Annual BIO Investor Forum 2009 2Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiary's Stock to Investors 2Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiary's Stock to Investors 3Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiary's Stock to Investors 4